Keros Therapeutics KROS
NASDAQ KROS
$11.35 +0.17 (+1.52%)
At close: Oct 22, 2026 · 4:00 PM EDT

Keros Therapeutics (KROS) Ending Cash Balance (2019 - 2026)

Updated

Analysis

Keros Therapeutics (KROS) Ending Cash Balance (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.57 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.03 Bn
10 Keros Therapeutics 224.56 Mn -1.70 Bn - 259.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 259.06 Mn
Dec 31, 2025 288.86 Mn
Sep 30, 2025 694.92 Mn
Jun 30, 2025 691.66 Mn
Mar 31, 2025 721.99 Mn
Dec 31, 2024 561.38 Mn
Sep 30, 2024 532.13 Mn
Jun 30, 2024 407.08 Mn
Mar 31, 2024 443.66 Mn
Dec 31, 2023 332.36 Mn
Sep 30, 2023 289.11 Mn
Jun 30, 2023 323.35 Mn
Mar 31, 2023 352.76 Mn
Dec 31, 2022 280.38 Mn
Sep 30, 2022 240.75 Mn
Jun 30, 2022 216.95 Mn
Mar 31, 2022 229.91 Mn
Dec 31, 2021 231.37 Mn
Sep 30, 2021 222.68 Mn
Jun 30, 2021 237.23 Mn
API Access

Keros Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=KROS&period=max&api_key=YOUR_API_KEY